CD 105(endoglin)是TGF-β超家族共受體,其促進血管生成,參與內(nèi)皮整合素介導(dǎo)的壁細胞和白細胞粘附,拮抗TGF-β介導(dǎo)的ERK活化,是巨噬細胞免疫應(yīng)答所必需的,調(diào)節(jié)妊娠期間滋養(yǎng)層分化和侵襲,促進T細胞增殖,并調(diào)節(jié)肌成纖維細胞中的分化和膠原表達 抗小鼠CD 105(MJ 7/18)體內(nèi)抗體-超低內(nèi)毒素該產(chǎn)品同種型對照:Rat IgG2a In Vivo Isotype Control – Low Endotoxin (1-1) 緩沖液:ICH3001-100ml,nICH3002-100ml,nICH3003-100ml, 濃度:≥ 2.0 mg/ml 純度:>98% by SDS-PAGE and HPLC 內(nèi)毒素:≤ 0.5 EU/mg as determined by the LAL method 制劑:Sterile, preservative-free, solution in PBS. BSA and Azide free.
MJ7/18 was produced by immunizing rats with inflamed mouse skin and selecting for reactivity with endothelial cells. MJ7/18 predominantly stains vascular endothelial cells and is a marker of mouse endothelium